PATHS™
(Parkinson's Disease Advanced Therapeutic Strategies)


Home

Register

Planning Committee

Program Description

Learning Objectives

Intended Audience

Credit Information

Disclosure Policy

Off-Label Policy

Help

Privacy Policy

Challenges in the Management of Parkinson's Disease: Current Options and Emerging Strategies

CME Dinner Meetings

Off-Label Policy

When an unlabeled use of a commercial product—or an investigational product not yet approved for any purpose—is discussed during an educational activity, the speaker is required to disclose that the product is not yet labeled for the use under discussion or to state that the product is still investigational.